Wells Fargo & Company Mirum Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$468 Billion
Q2 2025

A detailed history of Wells Fargo & Company transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 198,160 shares of MIRM stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

198,160

Previous 33,668 488.57%

Holding current value

$14.2 Million

Previous $1.52 Million 565.17%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$38.39 - $51.11 $6.31 Million - $8.41 Million	164,492 Added 488.57%	198,160 $10.1 Million
Q1 2025 May 13, 2025	SELL	$41.32 - $53.16 $283,372 - $364,571	-6,858 Reduced 16.92%	33,668 $1.52 Million
Q4 2024 Feb 12, 2025	SELL	$37.85 - $46.65 $2.55 Million - $3.15 Million	-67,501 Reduced 62.49%	40,526 $1.68 Million
Q3 2024 Nov 13, 2024	BUY	$33.68 - $44.74 $2.35 Million - $3.13 Million	69,913 Added 183.43%	108,027 $4.21 Million
Q2 2024 Aug 13, 2024	BUY	$23.57 - $34.85 $712,733 - $1.05 Million	30,239 Added 383.99%	38,114 $1.3 Million
Q1 2024 May 10, 2024	BUY	$24.92 - $30.02 $21,655 - $26,087	869 Added 12.4%	7,875 $197,000
Q4 2023 Feb 09, 2024	SELL	$27.14 - $34.93 $630,000 - $810,830	-23,213 Reduced 76.82%	7,006 $206,000
Q3 2023 Nov 13, 2023	SELL	$24.63 - $32.85 $13,324 - $17,771	-541 Reduced 1.76%	30,219 $954,000
Q2 2023 Aug 15, 2023	BUY	$23.51 - $30.09 $301,750 - $386,205	12,835 Added 71.6%	30,760 $795,000
Q1 2023 May 12, 2023	BUY	$19.19 - $24.1 $343,980 - $431,992	17,925 New	17,925 $430,000
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $5,674 - $8,360	284 Added 62.69%	737 $16,000
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $8,344 - $12,457	453 New	453 $9,000
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $325 - $502	-21 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $3,680 - $5,456	-282 Reduced 93.07%	21 $0
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $432 - $625	-31 Reduced 9.28%	303 $6,000
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $34,309 - $44,619	-2,166 Reduced 86.64%	334 $6,000
Q1 2021 May 13, 2021	SELL	$16.29 - $21.92 $269,404 - $362,512	-16,538 Reduced 86.87%	2,500 $50,000
Q4 2020 Feb 09, 2021	BUY	$15.75 - $25.45 $216,594 - $349,988	13,752 Added 260.16%	19,038 $332,000
Q3 2020 Nov 05, 2020	SELL	$18.4 - $26.59 $22,300 - $32,227	-1,212 Reduced 18.65%	5,286 $101,000
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $32,458 - $59,135	2,820 Added 76.67%	6,498 $126,000
Q1 2020 May 14, 2020	BUY	$9.38 - $23.79 $34,499 - $87,499	3,678 New	3,678 $51,000

Others Institutions Holding MIRM

# of Institutions

230

Shares Held

56.1M

Call Options Held

25.3K

Put Options Held

98.9K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Mirum Pharmaceuticals, Inc. Transaction History